Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.
作者信息
Tremblay Douglas, Vogel Alexander S, Moshier Erin, Hoffman Ronald, Kremyanskaya Marina, Zhou Selena, Schiano Thomas, Mascarenhas John
机构信息
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Division of Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
Eur J Haematol. 2020 Jan;104(1):72-73. doi: 10.1111/ejh.13335. Epub 2019 Oct 16.
Abstract
摘要
相似文献
1
Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.单中心经验中骨髓增殖性肿瘤患者内脏静脉血栓形成的结局
Eur J Haematol. 2020 Jan;104(1):72-73. doi: 10.1111/ejh.13335. Epub 2019 Oct 16.
2
Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.骨髓增殖性肿瘤患者的内脏静脉血栓形成：梅奥诊所连续84例病例的经验
Am J Hematol. 2018 Mar;93(3):E61-E64. doi: 10.1002/ajh.24993. Epub 2017 Dec 18.
3
Survival in patients with familial and sporadic myeloproliferative neoplasms.家族性和散发性骨髓增殖性肿瘤患者的生存情况。
Blood. 2015 Jun 4;125(23):3665-6. doi: 10.1182/blood-2015-04-639039.
4
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients.维奈托克联合低甲基化药物治疗急变期骨髓增殖性肿瘤：12例患者的初步经验
Br J Haematol. 2020 Dec;191(5):e120-e124. doi: 10.1111/bjh.17084. Epub 2020 Sep 18.
5
Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.由持续激活的JAK2 V617F费城阴性骨髓增殖性肿瘤驱动的内脏静脉血栓形成：一例报告
Afr Health Sci. 2014 Dec;14(4):1069-73. doi: 10.4314/ahs.v14i4.39.
6
Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.患有内脏静脉血栓形成的骨髓增殖性肿瘤患者的独特临床、实验室和分子特征。
Br J Haematol. 2018 Oct;183(2):310-313. doi: 10.1111/bjh.14958. Epub 2017 Oct 19.
7
Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.与骨髓增殖性肿瘤相关的内脏静脉血栓形成的异质性。
Eur J Intern Med. 2018 Jun;52:e25-e26. doi: 10.1016/j.ejim.2018.03.009. Epub 2018 Mar 20.
8
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.内脏静脉血栓形成在骨髓增殖性肿瘤中。
Curr Hematol Malig Rep. 2018 Jun;13(3):183-190. doi: 10.1007/s11899-018-0446-x.
9
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.不可分类骨髓增殖性肿瘤（MPN-U）的临床病理特征：来自英国大型三级转诊中心的回顾性分析。
Br J Haematol. 2021 May;193(4):792-797. doi: 10.1111/bjh.17375. Epub 2021 Mar 9.
10
Splanchnic vein thrombosis in acute pancreatitis: a single-center experience.急性胰腺炎合并肠系膜静脉血栓形成：单中心经验。
Pancreas. 2013 Nov;42(8):1251-4. doi: 10.1097/MPA.0b013e3182968ff5.
引用本文的文献
1
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific Challenges.骨髓增殖性肿瘤女性患者出血、血栓形成及妊娠相关并发症的管理：基于病例的综述，聚焦性别特异性挑战。
J Clin Med. 2025 Feb 25;14(5):1537. doi: 10.3390/jcm14051537.
2
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.根据脾静脉血栓形成及其时间顺序，对年轻的真性红细胞增多症和原发性血小板增多症患者进行基因组分类和结局评估。
Ann Hematol. 2024 Mar;103(3):737-747. doi: 10.1007/s00277-023-05610-x. Epub 2024 Jan 24.
3
Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.骨髓纤维化中的内脏静脉血栓形成——疾病表型的一个被低估的特征。
Int J Mol Sci. 2023 Oct 29;24(21):15717. doi: 10.3390/ijms242115717.
4
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs.骨髓增殖性肿瘤中的内脏静脉血栓形成：治疗考量与未满足的需求
Cancers (Basel). 2022 Dec 20;15(1):11. doi: 10.3390/cancers15010011.
5
Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.以门静脉、脾静脉和肠系膜上静脉血栓形成表现的纤维化前期原发性骨髓纤维化：1例报告并文献复习
GE Port J Gastroenterol. 2021 May 4;29(2):125-131. doi: 10.1159/000514658. eCollection 2022 Mar.
6
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.真性红细胞增多症和原发性血小板增多症患者减少血栓形成事件数量的治疗策略评估
Front Oncol. 2021 Feb 16;10:636675. doi: 10.3389/fonc.2020.636675. eCollection 2020.
7
Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.骨髓增殖性肿瘤概述：历史、发病机制、诊断标准及并发症。
Hematol Oncol Clin North Am. 2021 Apr;35(2):159-176. doi: 10.1016/j.hoc.2020.12.001. Epub 2021 Jan 26.
本文引用的文献
1
Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.骨髓增殖性肿瘤患者的内脏静脉血栓形成：梅奥诊所连续84例病例的经验
Am J Hematol. 2018 Mar;93(3):E61-E64. doi: 10.1002/ajh.24993. Epub 2017 Dec 18.
2
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm.γ-谷氨酰转移酶是骨髓增殖性肿瘤患者内脏血栓形成的独立生物标志物。
Medicine (Baltimore). 2016 May;95(20):e3355. doi: 10.1097/MD.0000000000003355.
3
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.内脏静脉血栓形成的长期临床结局：国际登记处的结果。
JAMA Intern Med. 2015 Sep;175(9):1474-80. doi: 10.1001/jamainternmed.2015.3184.
4
Thrombotic disease in the myeloproliferative neoplasms.骨髓增殖性肿瘤中的血栓性疾病。
Hematology Am Soc Hematol Educ Program. 2012;2012:571-81. doi: 10.1182/asheducation-2012.1.571.
5
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.非手术患者抗止血药品临床研究中严重出血的定义。
J Thromb Haemost. 2005 Apr;3(4):692-4. doi: 10.1111/j.1538-7836.2005.01204.x.
Zotero 插件